Description
Zefax-MF Tablets are a combination antibiotic therapy containing Moxifloxacin and Cefixime in a sustained-release formulation. This dual antibiotic combination is designed to provide broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria, making it effective in the treatment of various bacterial infections.
-
Moxifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, preventing bacterial replication and growth.
-
Cefixime is a third-generation cephalosporin that inhibits bacterial cell wall synthesis, causing bacterial cell death.
The sustained-release formulation ensures prolonged therapeutic action, reducing dosing frequency and improving patient compliance.
Benefits of Zefax-MF Tablets
Effective against a broad spectrum of bacterial infections.
Combines two mechanisms of action for enhanced antibacterial efficacy.
Sustained-release formulation allows once or twice-daily dosing, improving compliance.
Reduces duration and severity of infections.
Convenient oral therapy for outpatient and home treatment.
